Product image of Levemir Penfill (Insulin Detemir) supplied by GNH India

Levemir Penfill

Active Ingredient:
Insulin Detemir
Origin:
EU

Levemir Penfill (Insulin Detemir)

Insulin detemir, the active ingredient in Levemir Penfill, is a long‑acting insulin analog presented as an injectable solution (penfill) for subcutaneous use. It provides basal insulin coverage to treat diabetes mellitus in both type 1 and type 2 patients.
GNH India supplies Levemir Penfill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levemir Penfill is a long‑acting insulin analog used to manage blood glucose in diabetes mellitus.

  • Type 1 diabetes mellitus: provides basal insulin to maintain fasting glucose levels.
  • Type 2 diabetes mellitus: adds basal insulin when oral agents no longer achieve target glycaemia.
  • Adults requiring basal insulin therapy: offers once‑daily or twice‑daily dosing to support overall glucose control.

How It Works

  • Insulin detemir binds to insulin receptors on peripheral tissues, stimulating glucose uptake and utilization while inhibiting hepatic glucose production. Its fatty‑acid side chain promotes albumin binding, prolonging its duration of action and providing a stable basal insulin profile after subcutaneous injection.

Side Effects

Levemir Penfill may cause a range of adverse reactions.

Common Side Effects

  • Hypoglycaemia: low blood glucose episodes.
  • Injection site reactions: redness, swelling, or bruising.
  • Weight gain: increase in body weight over time.
  • Lipodystrophy: localized changes in fat tissue.
  • Edema: mild fluid retention.
  • Headache: occasional mild headache.

Serious or Rare Side Effects

  • Severe hypoglycaemia: potentially life‑threatening low glucose.
  • Anaphylactic reaction: rare allergic response requiring emergency care.
  • Serum insulin antibodies: may alter insulin effectiveness.
  • Hypokalemia: low potassium levels.
  • Severe skin necrosis at injection site.
  • Acute pancreatitis: rare inflammation of the pancreas.

Precautions & Warnings

Before using Levemir Penfill, consider the following precautions.

  • Dose adjustment: titrate based on glucose monitoring and clinical response.
  • Hypoglycaemia risk: educate patients on recognizing and treating low blood sugar.
  • Renal or hepatic impairment: may require lower doses and close monitoring.
  • Pregnancy and lactation: use only if benefits outweigh potential risks; consult a healthcare professional.
  • Concomitant medications: assess for agents that may mask hypoglycaemia or alter glucose levels.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Levemir Penfill can interact with other medicines, affecting glucose control.

Major Interactions (Avoid)

  • Sulfonylureas or meglitinides: increased risk of severe hypoglycaemia.
  • Beta‑blockers: may mask hypoglycaemia symptoms.
  • Systemic glucocorticoids: can raise blood glucose, reducing insulin effectiveness.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: may potentiate hypoglycaemia; monitor glucose.
  • Thiazide diuretics: can increase blood glucose; adjust insulin as needed.
  • Oral contraceptives: may slightly affect insulin requirements.
  • Alcohol: can cause unpredictable glucose fluctuations.

Frequently Asked Questions

Levemir Penfill is a long‑acting insulin analog indicated for basal insulin therapy in adults with type 1 or type 2 diabetes mellitus. It helps maintain stable fasting blood glucose levels when other treatments are insufficient.

Insulin detemir binds to insulin receptors, promoting glucose uptake in muscle and fat while suppressing hepatic glucose production. Its fatty‑acid side chain prolongs action by reversible albumin binding, providing a consistent basal insulin effect after subcutaneous injection.

The dose of Levemir Penfill is individualized. A qualified prescriber determines the starting amount and titration schedule based on the patient’s glucose monitoring, body weight, and overall treatment goals.

Levemir Penfill may be used in pregnancy or while breastfeeding only if the potential benefits justify any potential risk to the fetus or infant. Healthcare providers should evaluate each case and monitor glucose closely.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details and necessary import documentation.

Levemir Penfill (insulin detemir) offers a predictable, flat pharmacokinetic profile with once‑daily or twice‑daily dosing, similar to other long‑acting analogues such as glargine. Its albumin‑binding property may result in less variability, but choice depends on individual response, dosing convenience and clinician preference.

Levemir Penfill should be stored in a refrigerator at 2‑8 °C, protected from light. Do not freeze or shake the pen. Once in use, it may be kept at room temperature (up to 30 °C) for a maximum of 28 days, according to the manufacturer’s guidelines.

Levemir Penfill is administered subcutaneously using the pre‑filled pen device. Injections are typically given in the abdomen, thigh, or upper arm, rotating sites to reduce lipodystrophy. The prescriber determines the injection frequency and timing.

The most serious risks include severe hypoglycaemia, which can be life‑threatening, and rare allergic reactions such as anaphylaxis. Patients should be educated on recognizing symptoms and have a plan for immediate treatment.

Levemir Penfill is contraindicated in individuals with a known hypersensitivity to insulin detemir or any of the pen’s excipients. It should also be avoided in patients with severe hypoglycaemia unresponsive to treatment until the underlying cause is resolved.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Insulin Detemir

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT